Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosisResearch Published on 2024-06-192024-09-05 Journal: BMC Immunology [Category] update2024, [키워드] COVID-19 Disease-modifying therapy Immunity vaccine multiple sclerosis vaccine side effects [DOI] 10.1186/s12865-024-00628-w PMC 바로가기 [Article Type] Research
Practical Clinical Guidelines for Natalizumab Treatment in Patients With Relapsing Multiple SclerosisFeatures Published on 2023-11-062024-09-04 Journal: Journal of infusion nursing : the official publica [Category] 대상포진, [키워드] Disease-modifying therapy guidelines infusion monoclonal antibodies multiple sclerosis Natalizumab [DOI] 10.1097/NAN.0000000000000519 PMC 바로가기 [Article Type] Features
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugsReview Published on 2023-06-092024-09-04 Journal: Multiple Sclerosis Journal [Category] 대상포진, [키워드] Consensus Disease-modifying therapy infections multiple sclerosis vaccination [DOI] 10.1177/13524585231168043 PMC 바로가기 [Article Type] Review
Summary of Safety and Efficacy of COVID Vaccination in Patients with Multiple SclerosisBasic Investigative Studies: Review Article Published on 2023-03-042024-09-05 Journal: European neurology [Category] update2024, [키워드] COVID-19 Disease-modifying therapy multiple sclerosis SARS-CoV-2 Vaccine [DOI] 10.1159/000529982 PMC 바로가기 [Article Type] Basic Investigative Studies: Review Article
A retrospective evaluation of seroconversion after COVID-19 during the early Omicron wave in fully vaccinated multiple sclerosis patients receiving anti-CD20 therapiesArticle Published on 2023-02-152024-09-05 Journal: Multiple sclerosis and related disorders [Category] update2024, [키워드] anti-CD20 therapy COVID-19 Disease-modifying therapy multiple sclerosis Seroconversion vaccination [DOI] 10.1016/j.msard.2023.104574 PMC 바로가기 [Article Type] Article
Adhesión real al dimetilfumarato en pacientes con esclerosis múltiple remitente-recurrenteOriginal Published on 2023-01-242024-09-05 Journal: Revista de neurologia [Category] update2024, [키워드] COVID-19 dimethyl fumarate Dimetilfumarato Disease-modifying therapy DMF Esclerosis múltiple recurrente-remitente Evidencia en el mundo real Real-world evidence Relapsing-Remitting Multiple Sclerosis Tratamiento modificador de la enfermedad [DOI] 10.33588/rn.76S01.2022296 PMC 바로가기 [Article Type] Original
Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosisArticle Published on 2023-01-012023-07-11 Journal: EBioMedicine [Category] COVID19(2023년), [키워드] anti-CD20 Disease-modifying therapy S1P-Modulators SARS-CoV-2 vaccination titre. [DOI] 10.1016/j.ebiom.2022.104411 PMC 바로가기
Updates and advances in multiple sclerosis neurotherapeuticsarticle Published on 2022-10-312024-09-02 Journal: Neurodegenerative Disease Management [Category] 대상포진, [키워드] autologous hematopoietic stem cell transplantation BTK inhibitors Disease-modifying therapy early highly effective therapy escalation therapy multiple sclerosis neuroprotective agents Progressive multiple sclerosis relapsing multiple sclerosis remyelinating therapies [DOI] 10.2217/nmt-2021-0058 PMC 바로가기 [Article Type] article
Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter studyArticle Published on 2022-09-012022-11-15 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI Acetate anti-CD20 antibody Asymptomatic B-cell Course Disease-modifying therapy expected fumarate group healthy healthy control Heterologous homologous humoral Humoral response immune response Interferon-beta mAb majority median Mild multicenter Multiple multiple sclerosis Patient patients Probability Protective reached receiving reduced reported revaccination SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection Seroconversion significantly significantly lower study enrollment therapy Third U/mL vaccination was measured while [DOI] 10.1016/j.msard.2022.104009 PMC 바로가기
The Outcome of COVID-19 in Pediatric-Onset Multiple Sclerosis PatientsArticle Published on 2022-09-012023-07-09 Journal: Pediatric neurology [Category] COVID19(2023년), [키워드] COVID-19 Disease-modifying therapy Pediatric-onset multiple sclerosis severity [DOI] 10.1016/j.pediatrneurol.2022.06.004 PMC 바로가기